Analyzing Psychedelics & Traditional Pharma Interaction: New Clinical Trial Begins Dosing
Psychedelics biotech Small Pharma Inc. (OTCQB: DMTTF) confirmed that the first patient has been dosed in its Phase 1b study assessing the interaction between selective serotonin reuptake inhibitors (SSRIs) and proprietary lead DMT candidate SPL026 in patients with Major Depressive Disorder (MDD).
‘Fortnite’ Tricks Players To Purchase Stuff And Invades Children’s Privacy? Its Maker Will Pay $520M To Settle FTC Accusation
The Federal Trade Commission alleged that Epic Games’ “Fortnite” violated online privacy protection for children and tricked players into making unintended purchases.
Israeli Psychedelics Biotech Shares Latest Advancements, Moves Forward With Addictions Treatment
Psychedelics company Clearmind Medicine Inc. (NASDAQ: CMND) aims to bring its proprietary compound, CMND-100, to clinical trials while developing additional proprietary psychedelic compounds for next-generation novel drug candidates, according to CEO Adi Zuloff-Shani.
Epic Games To Pay More Than Half A Billion Dollars Over FTC Allegations Of Privacy Violations And Unwanted Charges
https://www.ftc.gov/news-events/news/press-releases/2022/12/fortnite-video-game-maker-epic-games-pay-more-half-billion-dollars-over-ftc-allegations